Some of the most common conditions patients present with are actually caused by inflammation. This presentation will explore how menopause and autoimmune diseases are actually inflammatory conditions. As autoimmune diseases continue to increase and affect more and more of our patients, the use of low-dose naltrexone (LDN) has been an emerging treatment option. Additional uses of LDN including weight loss, pain, and cancer will also be discussed. Join Sara Hover, RPH, Clinical Compounding Pharmacist as she shares the latest research on inflammation and LDN.
.svg){kind=small}
.svg){kind=small}
